基因检测在常染色体显性多囊肾病临床管理中不断演变的作用
常染色体显性多囊肾病(ADPKD)主要由PKD1和PKD2基因突变引起。有明确家族史时诊断多基于影像学标准,基因检测指征有限,且PKD1突变筛查因基因大、复杂(含六个假基因)和等位基因异质性而技术困难。近期研究揭示了ADPKD强基因型-表型相关性,二代测序(NGS)可高通量、准确、全面筛查多囊肾病及修饰基因,降低成本,为典型及非典型病例提供预后信息,推动个体化医疗。
要点
- 有ADPKD家族史者诊断多依据影像学标准,基因检测指征有限。
- PKD1突变筛查因基因大、含六个假基因及等位基因异质性而技术困难。
- NGS可高通量、准确、全面筛查多囊肾病及修饰基因,降低成本并提供预后信息。
核心结论
- ADPKD存在强基因型-表型相关性,基因检测指征正在演变。
- NGS为基础筛查有望为典型及非典型遗传病例提供重要预后信息,推进个体化医疗。
研究设计与样本
- 综述,讨论ADPKD基因检测不断演变的指征及NGS筛查的应用前景。
主要发现
- ADPKD主要由PKD1和PKD2基因突变引起。
- 有阳性家族史时,诊断多基于影像学既定标准,基因检测目前很少被指示。
- PKD1突变筛查因基因大、含六个高度相似假基因及广泛等位基因异质性而技术困难。
- 近期研究描述了ADPKD强基因型-表型相关性,并开始揭示非典型表型病例的遗传学基础。
临床怎么用
- 对于有家族史的典型ADPKD,影像学诊断为主,基因检测指征有限。
- NGS可全面筛查多囊肾病及修饰基因,为典型及非典型病例提供预后信息。
局限性
- PKD1突变筛查技术困难,因基因大、含六个假基因及等位基因异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD) is caused primarily by mutations of two genes, PKD1 and PKD2. In the presence of a positive family history of ADPKD, genetic testing is currently seldom indicated as the diagnosis is mostly based on imaging studies using well-established criteria. Moreover, PKD1 mutation screening is technically challenging due to its large size, complexity (i.e. presence of six pseudogenes with high levels of DNA sequence similarity) and extensive allelic heterogeneity. Despite these limitations, recent studies have delineated a strong genotype-phenotype correlation in ADPKD and begun to unravel the role of genetics underlying cases with atypical phenotypes. Furthermore, adaptation of next-generation sequencing (NGS) to clinical PKD genetic testing will provide a high-throughput, accurate and comprehensive screen of multiple cystic disease and modifier genes at a reduced cost. In this review, we discuss the evolving indications of genetic testing in ADPKD and how NGS-based screening promises to yield clinically important prognostic information for both typical as well as unusual genetic (e.g. allelic or genic interactions, somatic mosaicism, cystic kidney disease modifiers) cases to advance personalized medicine in the era of novel therapeutics for ADPKD.
引用
- Lanktree MB, Iliuta IA, Haghighi A, et al. Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2019. PMID: 30165646. doi:10.1093/ndt/gfy261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。